{"organizations": [], "uuid": "2b24825aed0934dab5f45e014bd5aea42ae8cbfd", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180417.html", "section_title": "Archive News &amp; Video for Tuesday, 17 Apr 2018 | Reuters.com", "url": "https://www.reuters.com/article/mylan-nl-pfizer-epipen/canada-says-working-with-u-s-fda-to-address-epipen-shortage-idUSL1N1RU1T3", "country": "US", "domain_rank": 408, "title": "Canada says working with U.S. FDA to address EpiPen shortage", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.912, "site_type": "news", "published": "2018-04-18T03:09:00.000+03:00", "replies_count": 0, "uuid": "2b24825aed0934dab5f45e014bd5aea42ae8cbfd"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/mylan-nl-pfizer-epipen/canada-says-working-with-u-s-fda-to-address-epipen-shortage-idUSL1N1RU1T3", "ord_in_thread": 0, "title": "Canada says working with U.S. FDA to address EpiPen shortage", "locations": [], "entities": {"persons": [{"name": "tom brown", "sentiment": "none"}, {"name": "anna mehler paperny", "sentiment": "none"}], "locations": [{"name": "canada", "sentiment": "none"}, {"name": "toronto", "sentiment": "none"}, {"name": "united states", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "neutral"}, {"name": "u.s. fda", "sentiment": "neutral"}, {"name": "health canada", "sentiment": "none"}, {"name": "mylan", "sentiment": "none"}, {"name": "u.s. food and drug administration", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "TORONTO, April 17 (Reuters) - Canada’s government health agency said on Tuesday it is working with the U.S. Food and Drug Administration to address a shortage of Mylan’s EpiPen allergy antidote that his hit several countries outside of the United States, where it is manufactured.\nThe efforts include “exploring access to international supply,” a Health Canada spokeswoman told Reuters in an emailed statement. (Reporting by Anna Mehler Paperny Editing by Tom Brown)\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-04-18T03:09:00.000+03:00", "crawled": "2018-04-18T18:15:10.000+03:00", "highlightTitle": ""}